Media Summary: We're a medicine company that helps make life better for people around the world. Hear directly from our incredible colleagues ... The pharmaceutical company is expanding its AI-driven drug development efforts through an agreement with Hong Kong-based ... Elanco Animal Health CEO Jeff Simmons on creating drugs for animals.

How Eli Lilly Is Disrupting - Detailed Analysis & Overview

We're a medicine company that helps make life better for people around the world. Hear directly from our incredible colleagues ... The pharmaceutical company is expanding its AI-driven drug development efforts through an agreement with Hong Kong-based ... Elanco Animal Health CEO Jeff Simmons on creating drugs for animals. CNBC's Jim Cramer delivers his daily Mad Dash. For access to live and exclusive video from CNBC subscribe to CNBC PRO: ... Jim Cramer breaks down why he's keeping an eye on shares of

Photo Gallery

Why Lilly?
Sectors Up Close: What helped Eli Lilly win obesity wars? | REUTERS
Eli Lilly CEO talks deal to cut medication prices with the Trump administration
Eli Lilly inks $2.8B AI drug discovery deal
An Obesity shot from Eli Lilly helped some people lose 23% of body weight
Eli Lilly CEO explains White House medication cost deal
Eli Lilly's Obesity Pill Moves Closer to Approval
AI and GLP-1 drugs: Eli Lilly & Co.'s CEO talks of focus beyond 150 years
Eli Lilly spin-off Elanco creating ‘disruptive’ opportunity in animal health: CEO
Eli Lilly CEO: Seeing global demand for weight loss drug Mounjaro
Cramer’s Mad Dash: Eli Lilly
Cramer's Stop Trading: Eli Lilly
View Detailed Profile
Why Lilly?

Why Lilly?

We're a medicine company that helps make life better for people around the world. Hear directly from our incredible colleagues ...

Sectors Up Close: What helped Eli Lilly win obesity wars? | REUTERS

Sectors Up Close: What helped Eli Lilly win obesity wars? | REUTERS

Eli Lilly

Eli Lilly CEO talks deal to cut medication prices with the Trump administration

Eli Lilly CEO talks deal to cut medication prices with the Trump administration

NBC News' Tom Llamas talks to CEO of

Eli Lilly inks $2.8B AI drug discovery deal

Eli Lilly inks $2.8B AI drug discovery deal

The pharmaceutical company is expanding its AI-driven drug development efforts through an agreement with Hong Kong-based ...

An Obesity shot from Eli Lilly helped some people lose 23% of body weight

An Obesity shot from Eli Lilly helped some people lose 23% of body weight

A next-generation obesity shot from

Eli Lilly CEO explains White House medication cost deal

Eli Lilly CEO explains White House medication cost deal

Eli Lilly

Eli Lilly's Obesity Pill Moves Closer to Approval

Eli Lilly's Obesity Pill Moves Closer to Approval

Eli Lilly

AI and GLP-1 drugs: Eli Lilly & Co.'s CEO talks of focus beyond 150 years

AI and GLP-1 drugs: Eli Lilly & Co.'s CEO talks of focus beyond 150 years

Eli Lilly

Eli Lilly spin-off Elanco creating ‘disruptive’ opportunity in animal health: CEO

Eli Lilly spin-off Elanco creating ‘disruptive’ opportunity in animal health: CEO

Elanco Animal Health CEO Jeff Simmons on creating drugs for animals.

Eli Lilly CEO: Seeing global demand for weight loss drug Mounjaro

Eli Lilly CEO: Seeing global demand for weight loss drug Mounjaro

Eli Lilly

Cramer’s Mad Dash: Eli Lilly

Cramer’s Mad Dash: Eli Lilly

CNBC's Jim Cramer delivers his daily Mad Dash. For access to live and exclusive video from CNBC subscribe to CNBC PRO: ...

Cramer's Stop Trading: Eli Lilly

Cramer's Stop Trading: Eli Lilly

Jim Cramer breaks down why he's keeping an eye on shares of

Eli Lilly to offer weight loss drug directly to qualifying customers at lower price

Eli Lilly to offer weight loss drug directly to qualifying customers at lower price

Drugmaker